Results 301 to 310 of about 56,186 (320)
Some of the next articles are maybe not open access.
NTRK fusion-positive cancers and TRK inhibitor therapy
Nature Reviews Clinical Oncology, 2018Emiliano Cocco +2 more
exaly
SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN
Ca-A Cancer Journal for Clinicians, 2005exaly
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Nature Reviews Cancer, 2019Jonathan J Havel +2 more
exaly
Interplay between β-lactamases and new β-lactamase inhibitors
Nature Reviews Microbiology, 2019Karen Bush, Patricia A Bradford
exaly
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Nature Reviews Drug Discovery, 2006Brian Schwartz
exaly